Glucagon-Like Peptide-1 Receptor Agonists in the Peri-Operative Period.

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

British journal of hospital medicine Pub Date : 2025-01-24 Epub Date: 2025-01-09 DOI:10.12968/hmed.2024.0566

Purnima Narasimhan

引用次数: 0

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are emerging as an important class of drugs in the management of Type 2 Diabetes Mellitus (T2DM) and obesity. There are rising concerns of pulmonary aspiration with these medications due to drug-induced gastroparesis. While definitive association is uncertain, it is essential to be prudent and manage these patients as per the current evidence and recommendations.

查看原文本刊更多论文

胰高血糖素样肽-1受体激动剂在围手术期的应用。

胰高血糖素样肽-1受体激动剂（GLP-1 RAs）正在成为治疗2型糖尿病（T2DM）和肥胖的重要药物。由于药物性胃轻瘫，越来越多的人担心这些药物会引起肺部误吸。虽然明确的关联是不确定的，但根据目前的证据和建议谨慎对待和管理这些患者是至关重要的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British journal of hospital medicine 医学-医学：内科

CiteScore

1.50

自引率

0.00%

发文量

176

审稿时长

4-8 weeks

期刊介绍： British Journal of Hospital Medicine was established in 1966, and is still true to its origins: a monthly, peer-reviewed, multidisciplinary review journal for hospital doctors and doctors in training. The journal publishes an authoritative mix of clinical reviews, education and training updates, quality improvement projects and case reports, and book reviews from recognized leaders in the profession. The Core Training for Doctors section provides clinical information in an easily accessible format for doctors in training. British Journal of Hospital Medicine is an invaluable resource for hospital doctors at all stages of their career. The journal is indexed on Medline, CINAHL, the Sociedad Iberoamericana de Información Científica and Scopus.